Abstract:The advancement in pharmaceutical research has led to the discovery and development of new combinatorial life-saving drugs. Rapamycin is a macrolide compound produced from Streptomyces hygroscopicus. Rapamycin and its derivatives are one of the promising sources of drug with broad spectrum applications in the medical field. In recent times, rapamycin has gained significant attention as of its activity against cytokine storm in COVID-19 patients. Rapamycin and its derivatives have more potency when compared to other prevailing drugs. Initially, it has been used exclusively as an anti-fungal drug. Currently rapamycin has been widely used as an immunosuppressant. Rapamycin is a multifaceted drug; it has anti-cancer, anti-viral and anti-aging potentials. Rapamycin has its specific action on mTOR signaling pathway. mTOR has been identified as a key regulator of different pathways. There will be an increased demand for rapamycin, because it has lesser adverse effects when compared to steroids. Currently researchers are focused on the production of effective rapamycin derivatives to combat the growing demand of this wonder drug. The main focus of the current review is to explore the origin, development, molecular mechanistic action, and the current therapeutic aspects of rapamycin. Also, this review article revealed the potential of rapamycin and the progress of rapamycin research. This helps in understanding the exact potency of the drug and could facilitate further studies that could fill in the existing knowledge gaps. The study also gathers significant data pertaining to the gene clusters and biosynthetic pathways involved in the synthesis and production of this multi-faceted drug. In addition, an insight into the mechanism of action of the drug and important derivatives of rapamycin has been expounded. The fillings of the current review, aids in understanding the underlying molecular mechanism, strain improvement, optimization and production of rapamycin derivatives.

Production of Novel Rapamycin Analogs by Precursor-Directed Biosynthesis

Novel sulfur-containing rapamycin analogs prepared by precursor-directed biosynthesis.

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Insights into the Metabolic Mechanism of Rapamycin Overproduction in the Shikimate-Resistant Streptomyces Hygroscopicus Strain Uv-Ii Using Comparative Metabolomics

Comparative Metabolic Profiling Reveals the Key Role of Amino Acids Metabolism in the Rapamycin Overproduction by Streptomyces Hygroscopicus

Comparative Metabolic Profiling-Based Improvement of Rapamycin Production by Streptomyces Hygroscopicus

Rifamycin Biosynthetic Congeners: Isolation and Total Synthesis of Rifsaliniketal and Total Synthesis of Salinisporamycin and Saliniketals A and B

Comparative analysis of rapamycin biosynthesis clusters between Actinoplanes sp. N902-109 and Streptomyces hygroscopicus ATCC29253

43-O-(β-d-glucoside)-rapamycin, a Microbial Conversion Product by Bacillus Subtilis CGMCC7764

14-deoxorapamycin, the microbial conversion product of rapamycin by Micromonospora chersina FIM03-712

Enhancement of Rapamycin Production by Metabolic Engineering in Streptomyces Hygroscopicus Based on Genome-Scale Metabolic Model

Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used As Potential Mtor‐targeted Anticancer Agents

Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

Design, Synthesis and Biological Evaluation of Novel Rapamycin Benzothiazole Hybrids As Mtor Targeted Anti-cancer Agents

Hyper-Synergistic Antifungal Activity of Rapamycin and Peptide-Like Compounds against Candida albicans Orthogonally via Tor1 Kinase

Synthesis and Anticancer Activity of Novel Rapamycin C-28 Containing Triazole Moiety Compounds

7-O-ethyl-rapamycin produced by rapamycin producing strain mutant FC904-107

Isolation and identification of rapamycin dialdehyde

Structure of prolylrapamycin: confirmation through a revised and detailed NMR assignment study

Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine

New process control strategy used in a rapamycin fermentation